Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (371-380 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|April 14, 2025
Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working partyIman Abou Dalle, Myriam Labopin, Irma Khvedelidze, et al.
American Journal of Hematology|April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Socié Gérard, et al.
Clinical Rheumatology|January 22, 2019
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Perrine Guillaume-Jugnot, Manuela Badoglio, Myriam Labopin, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.
Hemasphere|September 25, 2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMTFrancesco Saraceni, Myriam Labopin, Anna M Raiola, et al.
Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Haematologica|October 22, 2013
Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in FranceMyriam Labopin, Annalisa Ruggeri, Norbert Claude Gorin, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 45

Showing results (371-380 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|April 14, 2025
Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working partyIman Abou Dalle, Myriam Labopin, Irma Khvedelidze, et al.
American Journal of Hematology|April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Socié Gérard, et al.
Clinical Rheumatology|January 22, 2019
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Perrine Guillaume-Jugnot, Manuela Badoglio, Myriam Labopin, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.
Hemasphere|September 25, 2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMTFrancesco Saraceni, Myriam Labopin, Anna M Raiola, et al.
Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Haematologica|October 22, 2013
Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in FranceMyriam Labopin, Annalisa Ruggeri, Norbert Claude Gorin, et al.
Bone Marrow Transplantation|October 7, 2024
An international survey to better understand the current incidence, severity, and management of VOD/SOSMarion Larue, Myriam Labopin, Eolia Brissot, et al.
Pageof 45